Condition: Postural Orthostatic Tachycardia Syndrome (POTS) · Healthy · Sponsor: University of Copenhagen
This study will describe the interplay between the gut hormones GIP and CCK and their regulation of blood flow to the large vessels in patients with Postural Orthostatic Tachycardia Syndrome (POTS) and GIP, CCK and GLP-1 in healthy. This is addressed by hormone infusions during MR-scans of the abdomen and intake of oral glucose.
This description comes directly from the study's public registry record.
Sophie W Nielsen, MD · + 45 27 26 79 94 · sophie.nielsen@sund.ku.dk
Lærke S Gasbjerg, MD, PhD · +45 25 34 68 94 · lsg@sund.ku.dk
Always discuss trial participation with your own doctor first.
| Rigshospitalet | Copenhagen, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07019519